Latest Breaking News On - Rezolute inc - Page 7 : comparemela.com

Rezolute to Participate in BTIG's 3rd Annual Ophthalmology Day -November 17, 2023 at 08:01 am EST

REDWOOD CITY, Calif., Nov. 17, 2023 Rezolute, Inc. , a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases,.

Stephanie-carrington
Rezolute-inc
Securities-exchange
Nasdaq
Annual-ophthalmology-day
Securities-act
Securities-exchange-act
Private-securities-litigation-reform-act
Risk-factors
Annual-report
Quarterly-reports
Markets

Rezolute Inc. (RZLT) Files $200M Mixed Shelf

Rezolute Inc. (RZLT) Files $200M Mixed Shelf
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Rezolute-inc
Nasdaq

Rezolute Inc. (RZLT) Receives PRIME Eligibility from European Medicines Agency for Enhanced Regulatory Support of RZ358 in Congenital Hyperinsulinism

Rezolute Inc. (RZLT) Receives PRIME Eligibility from European Medicines Agency for Enhanced Regulatory Support of RZ358 in Congenital Hyperinsulinism
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Susan-stewart
European-medicines-agency
Nasdaq
Rezolute-inc
Priority-medicines
Chief-regulatory-officer

Rezolute Receives Priority Medicines (PRIME) Eligibility from European Medicines Agency for ...

REDWOOD CITY, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today

United-states
Stephanie-carrington
Susan-stewart
European-medicines-agency
Securities-exchange
Nasdaq
European-union
Rezolute-inc
Priority-medicines
Chief-regulatory-officer
Orphan-drug-designation
Pediatric-rare-disease-designation

Rezolute (NASDAQ:RZLT) Shares Down 2.6%

Rezolute, Inc. (NASDAQ:RZLT – Get Free Report) shares were down 2.6% during mid-day trading on Friday . The stock traded as low as $0.81 and last traded at $0.87. Approximately 51,270 shares were traded during mid-day trading, an increase of 58% from the average daily volume of 32,480 shares. The stock had previously closed at […]

United-states
Rezolute-inc
Rezolute-company-profile
Charles-schwab-investment-management-inc
Millennium-management
Cantor-fitzgerald
Renaissance-technologies
Nasdaq
Get-free-report
Trading-down
Street-corp